Published in Curr Cardiol Rev on August 01, 2011
Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells attenuate limb ischemia by promoting angiogenesis in mice. Stem Cell Res Ther (2015) 1.01
Human umbilical cord tissue-derived mesenchymal stromal cells attenuate remodeling after myocardial infarction by proangiogenic, antiapoptotic, and endogenous cell-activation mechanisms. Stem Cell Res Ther (2014) 0.95
Ultrasound-mediated drug delivery for cardiovascular disease. Expert Opin Drug Deliv (2013) 0.93
Serum and supplement optimization for EU GMP-compliance in cardiospheres cell culture. J Cell Mol Med (2014) 0.90
A novel closed-chest porcine model of chronic ischemic heart failure suitable for experimental research in cardiovascular disease. Biomed Res Int (2013) 0.86
Stem cell death and survival in heart regeneration and repair. Apoptosis (2016) 0.84
Improved targeting and enhanced retention of the human, autologous, fibroblast-derived, induced, pluripotent stem cells to the sarcomeres of the infarcted myocardium with the aid of the bioengineered, heterospecific, tetravalent antibodies. J Stem Cell Res Ther (2013) 0.83
Cardiac regeneration in model organisms. Curr Treat Options Cardiovasc Med (2014) 0.79
Trophic actions of bone marrow-derived mesenchymal stromal cells for muscle repair/regeneration. Cells (2012) 0.78
Preclinical stem cell therapy in Chagas Disease: Perspectives for future research. World J Transplant (2013) 0.75
Stem cells: An eventual treatment option for heart diseases. World J Stem Cells (2015) 0.75
A reversal of age-dependent proliferative capacity of endothelial progenitor cells from different species origin in in vitro condition. J Cardiovasc Thorac Res (2016) 0.75
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell (2010) 15.58
Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet (2004) 9.35
Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res (2008) 8.49
Retracted Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst. Science (2004) 7.37
Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation (2002) 7.14
Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med (2006) 6.77
Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest (2001) 6.59
Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation (1968) 5.52
Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation (2003) 5.34
Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med (2005) 5.24
Connexin43: a protein from rat heart homologous to a gap junction protein from liver. J Cell Biol (1987) 5.22
Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol (2003) 4.91
Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol (2004) 4.50
Neural progenitors from human embryonic stem cells. Nat Biotechnol (2001) 4.48
Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci U S A (2002) 4.20
Isolation of a primate embryonic stem cell line. Proc Natl Acad Sci U S A (1995) 3.85
Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation (2005) 3.83
Unique gene expression signatures of independently-derived human embryonic stem cell lines. Hum Mol Genet (2004) 3.77
Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A (2002) 3.66
Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nat Biotechnol (2002) 3.52
The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation (2008) 3.30
Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med (1998) 3.28
Multilineage differentiation from human embryonic stem cell lines. Stem Cells (2001) 3.22
Myoblast transplantation for heart failure. Lancet (2001) 2.71
Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat Methods (2009) 2.64
Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J Am Coll Cardiol (2003) 2.56
Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci U S A (2002) 2.53
Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. Proc Natl Acad Sci U S A (2009) 2.51
Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol (2003) 2.35
Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest (1996) 2.20
Insulin production by human embryonic stem cells. Diabetes (2001) 2.20
Long-term culture of human embryonic stem cells in feeder-free conditions. Dev Dyn (2004) 2.01
Human feeder layers for human embryonic stem cells. Biol Reprod (2003) 1.94
Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regeneration. Proc Natl Acad Sci U S A (2001) 1.81
Good manufacturing practice and clinical-grade human embryonic stem cell lines. Hum Mol Genet (2008) 1.76
Bone marrow stem cells regenerate infarcted myocardium. Pediatr Transplant (2003) 1.66
Properties of four human embryonic stem cell lines maintained in a feeder-free culture system. Dev Dyn (2004) 1.60
Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina. Am Heart J (2006) 1.59
Engraftment and tumor formation after allogeneic in utero transplantation of primate embryonic stem cells. Transplantation (2003) 1.51
Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions. Stem Cells (2010) 1.42
Cardiomyocyte differentiation of mouse and human embryonic stem cells. J Anat (2002) 1.38
Catheter-based delivery of cells to the heart. Nat Clin Pract Cardiovasc Med (2006) 1.36
Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance. Proc Natl Acad Sci U S A (2007) 1.34
Epigenetic modification is central to genome reprogramming in somatic cell nuclear transfer. Stem Cells (2005) 1.33
Testing of nine different xeno-free culture media for human embryonic stem cell cultures. Hum Reprod (2007) 1.30
Strategies for directing the differentiation of stem cells into the cardiomyogenic lineage in vitro. Cardiovasc Res (2004) 1.29
Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation (2002) 1.27
Derivation of a xeno-free human embryonic stem cell line. Stem Cells (2006) 1.26
Adult stem cells: assessing the case for pluripotency. Trends Cell Biol (2002) 1.26
Substantial variation in the cardiac differentiation of human embryonic stem cell lines derived and propagated under the same conditions--a comparison of multiple cell lines. Ann Med (2009) 1.18
Simultaneous autologous transplantation of cocultured mesenchymal stem cells and skeletal myoblasts improves ventricular function in a murine model of Chagas disease. Circulation (2006) 1.15
Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation. J Am Coll Cardiol (2003) 1.15
Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty. Int J Cardiol (2004) 1.14
Identification of cell surface proteins for antibody-based selection of human embryonic stem cell-derived cardiomyocytes. J Proteome Res (2010) 1.11
Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J (2003) 1.10
Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial. Eur Heart J (2005) 1.07
Transplantation of autologous fresh bone marrow into infarcted myocardium: a word of caution. Circulation (2003) 1.05
Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg (2000) 1.05
Human embryonic stem cell-derived cardiomyocytes: demonstration of a portion of cardiac cells with fairly mature electrical phenotype. Exp Biol Med (Maywood) (2010) 1.02
Derivation, growth and applications of human embryonic stem cells. Reproduction (2004) 1.02
Embryonic stem cells: a promising tool for cell replacement therapy. J Cell Mol Med (2004) 0.98
Myocardial tissue engineering with autologous myoblast implantation. J Thorac Cardiovasc Surg (1998) 0.95
Strategies for ensuring that regenerative cardiomyocytes function properly and in cooperation with the host myocardium. Exp Mol Med (2010) 0.89
An overview and synopsis of techniques for directing stem cell differentiation in vitro. Cell Tissue Res (2004) 0.89
Myocardial replacement therapy. Circulation (2003) 0.84
Embryonic stem cells pace the heart. Nat Biotechnol (2004) 0.83
Embryonic stem cells: meeting the needs for cell therapy. Adv Drug Deliv Rev (2005) 0.83
Myocardial repair by percutaneous cell transplantation of autologous skeletal myoblast as a stand alone procedure in post myocardial infarction chronic heart failure patients. EuroIntervention (2006) 0.82
Potential applications of human embryonic stem cell-derived cardiomyocytes. Ann N Y Acad Sci (2004) 0.82
Could the coculture of skeletal myoblasts and mesenchymal stem cells be a solution for postinfarction myocardial scar? Transplant Proc (2004) 0.81
Cell transplantation: differential effects of myoblasts and mesenchymal stem cells. Int J Cardiol (2005) 0.81
Use of human gametes obtained from anonymous donors for the production of human embryonic stem cell lines. Fertil Steril (2001) 0.79
Regeneration of the myocardium: a new role in the treatment of ischemic heart disease? Hypertension (2001) 0.79
Percutaneous autologous myoblast transplantation in the treatment of post-infarction myocardial contractility impairment--report on two cases. Kardiol Pol (2003) 0.78
Combined transplantation of skeletal myoblasts and mesenchymal cells (cocultivation) in ventricular dysfunction after myocardial infarction. Arq Bras Cardiol (2004) 0.78
Functional outcome of bone marrow stem cells: mononuclear versus mesenchymal stem cells after cellular therapy in myocardial scar in Wistar rats. Transplant Proc (2006) 0.77
Comments about possible use of human embryonic stem cell-derived cardiomyocytes to direct autologous adult stem cells into the cardiomyogenic lineage. Acta Cardiol (2005) 0.77
Autologous skeletal myoblasts for myocardial regeneration. J Interv Cardiol (2004) 0.77
Potential utility of cell-permeable transcription factors to direct stem cell differentiation. Stem Cells Dev (2004) 0.77
Biointerventional cardiology: the future interface of interventional cardiovascular medicine and bioengineering. Vasc Med (2002) 0.76
MicroRNA-133 controls cardiac hypertrophy. Nat Med (2007) 11.68
Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. Cell (2013) 4.99
ErbB2 is essential in the prevention of dilated cardiomyopathy. Nat Med (2002) 3.36
MicroRNAs and cardiac pathology. Nat Rev Cardiol (2009) 2.50
Emerging role of microRNAs in cardiovascular biology. Circ Res (2007) 2.41
MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ Res (2009) 2.40
Association of the FOXO3A locus with extreme longevity in a southern Italian centenarian study. Rejuvenation Res (2009) 2.24
Relation of various plasma growth factor levels in patients with stable angina pectoris and total occlusion of a coronary artery to the degree of coronary collaterals. Am J Cardiol (2005) 2.14
CaMK4 Gene Deletion Induces Hypertension. J Am Heart Assoc (2012) 2.14
Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease. JACC Cardiovasc Interv (2013) 2.11
Akt mediates the cross-talk between beta-adrenergic and insulin receptors in neonatal cardiomyocytes. Circ Res (2004) 2.08
MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. J Clin Invest (2010) 2.04
Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation (2009) 2.02
Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia. Circulation (2011) 1.99
Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation (2009) 1.92
IkappaB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation. Proc Natl Acad Sci U S A (2011) 1.87
MicroRNAs: components of an integrated system controlling cardiac development, physiology, and disease pathogenesis. Cardiovasc Res (2008) 1.75
MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nat Cell Biol (2010) 1.74
Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res (2013) 1.72
MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Circ Res (2011) 1.67
Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells. Cardiovasc Res (2011) 1.67
MicroRNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro. J Cell Biol (2010) 1.64
Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina. Am Heart J (2006) 1.59
Rheb is a critical regulator of autophagy during myocardial ischemia: pathophysiological implications in obesity and metabolic syndrome. Circulation (2012) 1.56
MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/-mice. Thromb Haemost (2014) 1.53
Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine. Kidney Int (2005) 1.52
Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy. J Cell Physiol (2008) 1.48
SOCS1 gene transfer accelerates the transition to heart failure through the inhibition of the gp130/JAK/STAT pathway. Cardiovasc Res (2012) 1.48
Mechanism of enhanced cardiac function in mice with hypertrophy induced by overexpressed Akt. J Biol Chem (2003) 1.47
Association between insulin like growth factor-1 and lipoprotein metabolism in stable angina patients on statin therapy: a pilot study. Kardiol Pol (2012) 1.43
TET2 and CSMD1 genes affect SBP response to hydrochlorothiazide in never-treated essential hypertensives. J Hypertens (2015) 1.43
Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail (2011) 1.40
Echocardiographic evaluation of percutaneous valve repair in patients with mitral regurgitation using the CARILLON system. Kardiol Pol (2010) 1.40
Value of rotational angiography (3D-ATG) with contrast agent administration into the right atrium during atrial fibrillation ablation procedures: a preliminary report. Kardiol Pol (2012) 1.40
Functional assessment of patients after percutaneous mitral valvuloplasty with Carillon™ device: a preliminary report. Kardiol Pol (2011) 1.38
Catheter-based delivery of cells to the heart. Nat Clin Pract Cardiovasc Med (2006) 1.36
Physiological myocardial hypertrophy: how and why? Front Biosci (2008) 1.35
MicroRNA and cardiac pathologies. Physiol Genomics (2008) 1.32
Interval training normalizes cardiomyocyte function, diastolic Ca2+ control, and SR Ca2+ release synchronicity in a mouse model of diabetic cardiomyopathy. Circ Res (2009) 1.29
Akt regulates L-type Ca2+ channel activity by modulating Cavalpha1 protein stability. J Cell Biol (2009) 1.28
Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial. Circulation (2005) 1.28
Transplantation of low dose CD34+KDR+ cells promotes vascular and muscular regeneration in ischemic limbs. FASEB J (2004) 1.27
Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure. Cardiovasc Res (2008) 1.26
Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy. Eur Heart J (2012) 1.24
Circulating microRNAs and aerobic fitness--the HUNT-Study. PLoS One (2013) 1.20
MicroRNAs in cardiovascular biology and heart disease. Circ Cardiovasc Genet (2009) 1.19
Regulation of cell size and contractile function by AKT in cardiomyocytes. Ann N Y Acad Sci (2004) 1.19
Association study on long-living individuals from Southern Italy identifies rs10491334 in the CAMKIV gene that regulates survival proteins. Rejuvenation Res (2011) 1.17
Induced pluripotent stem cell-derived cardiomyocytes in studies of inherited arrhythmias. J Clin Invest (2013) 1.17
Akt/protein kinase B and endothelial nitric oxide synthase mediate muscular neovascularization induced by tissue kallikrein gene transfer. Circulation (2004) 1.15
AKT participates in endothelial dysfunction in hypertension. Circulation (2004) 1.15
Electrophysiology of human cardiac atrial and ventricular telocytes. J Cell Mol Med (2014) 1.14
Myocardial sarcoplasmic reticulum Ca2+ ATPase function is increased by aerobic interval training. Eur J Cardiovasc Prev Rehabil (2008) 1.13
Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy. Proc Natl Acad Sci U S A (2013) 1.13
Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells. Int J Cardiol (2013) 1.11
Correlations between progression of coronary artery disease and circulating endothelial progenitor cells. FASEB J (2010) 1.10
Heart infarct in NOD-SCID mice: therapeutic vasculogenesis by transplantation of human CD34+ cells and low dose CD34+KDR+ cells. FASEB J (2004) 1.09
MicroRNAs control gene expression: importance for cardiac development and pathophysiology. Ann N Y Acad Sci (2008) 1.09
Akt increases sarcoplasmic reticulum Ca2+ cycling by direct phosphorylation of phospholamban at Thr17. J Biol Chem (2009) 1.09
Aerobic interval training enhances cardiomyocyte contractility and Ca2+ cycling by phosphorylation of CaMKII and Thr-17 of phospholamban. J Mol Cell Cardiol (2007) 1.08
MiR-133a regulates collagen 1A1: potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension. J Cell Physiol (2012) 1.07
One-step derivation of cardiomyocytes and mesenchymal stem cells from human pluripotent stem cells. Stem Cell Res (2012) 1.06
Seasonal succession of Cylindrospermopsis raciborskii and Aphanizomenon ovalisporum blooms with cylindrospermopsin occurrence in the volcanic Lake Albano, Central Italy. Environ Toxicol (2010) 1.06
Long noncoding RNA: a new player of heart failure? J Cardiovasc Transl Res (2013) 1.05
Ischaemic heart disease deaths in Brazil: current trends, regional disparities and future projections. Heart (2013) 1.02
MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolism. J Transl Med (2011) 1.01
Primary Ewings sarcoma of the spine: case report. Arq Neuropsiquiatr (2006) 1.01
Doubly heterozygous LMNA and TTN mutations revealed by exome sequencing in a severe form of dilated cardiomyopathy. Eur J Hum Genet (2013) 1.00
c-Myc oncoprotein: cell cycle-related events and new therapeutic challenges in cancer and cardiovascular diseases. Cell Cycle (2003) 1.00
Cardiotoxic effects, or lack thereof, of anti-ErbB2 immunoagents. FASEB J (2009) 0.95
Opposing roles of Akt and STAT3 in the protection of the maternal heart from peripartum stress. Cardiovasc Res (2014) 0.95
Epigenetics: a new mechanism of regulation of heart failure? Basic Res Cardiol (2013) 0.94
Molecular determinants of the physiological adaptation to stress in the cardiomyocyte: a focus on AKT. J Mol Cell Cardiol (2004) 0.94
Effects of Akt on cardiac myocytes: location counts. Circ Res (2006) 0.94
Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosis. Proc Natl Acad Sci U S A (2002) 0.93
Cell delivery and tracking in post-myocardial infarction cardiac stem cell therapy: an introduction for clinical researchers. Heart Fail Rev (2010) 0.93
Fatty acid percentage in erythrocyte membranes of atrial flutter/fibrillation patients and controls. J Interv Card Electrophysiol (2010) 0.93
Circulating microRNAs as potential biomarkers of coronary artery disease: a promise to be fulfilled? Circ Res (2010) 0.93
Hemodynamic contribution of stem cell scaffolding in acute injured myocardium. Tissue Eng Part A (2012) 0.92
microRNAs in hypertrophy and heart failure. Exp Biol Med (Maywood) (2011) 0.92
Assessment of the 9p21.3 locus in severity of coronary artery disease in the presence and absence of type 2 diabetes. BMC Med Genet (2013) 0.90
Identification and characterization of calcium sparks in cardiomyocytes derived from human induced pluripotent stem cells. PLoS One (2013) 0.90
Role of microRNAs in haemopoiesis, heart hypertrophy and cancer. Biochem Soc Trans (2008) 0.89
MicroRNA-1 downregulation increases connexin 43 displacement and induces ventricular tachyarrhythmias in rodent hypertrophic hearts. PLoS One (2013) 0.89
Differential effect of myocardial matrix and integrins on cardiac differentiation of human mesenchymal stem cells. Differentiation (2010) 0.88
RNA silencing: small RNA-mediated posttranscriptional regulation of mRNA and the implications for heart electropathophysiology. J Cardiovasc Electrophysiol (2008) 0.87
Are elevated levels of IGF-1 caused by coronary arteriesoclerosis?: Molecular and clinical analysis. Protein J (2010) 0.85
iPSC-derived human mesenchymal stem cells improve myocardial strain of infarcted myocardium. J Cell Mol Med (2014) 0.85
Pharmacoelectrophysiology of viral-free induced pluripotent stem cell-derived human cardiomyocytes. Toxicol Sci (2012) 0.85
Unexpectedly low mutation rates in beta-myosin heavy chain and cardiac myosin binding protein genes in Italian patients with hypertrophic cardiomyopathy. J Cell Physiol (2011) 0.85
Reliable resequencing of the human dystrophin locus by universal long polymerase chain reaction and massive pyrosequencing. Anal Biochem (2010) 0.85
Human embryonic stem cell-derived cardiomyocytes: inducing strategies. Regen Med (2006) 0.84
Steering signal transduction pathway towards cardiac lineage from human pluripotent stem cells: a review. Cell Signal (2013) 0.84
Presence of irregularity in region between -1115 and -784 nt in P1 promoter of insulin-like growth factor-1 gene may indicate beneficial effect on coronary arteries in a group of patients with stable angina: preliminary data. Heart Vessels (2009) 0.84
Intraobserver and interobserver reliability of the three-dimensional ultrasound imaging of female urethral sphincter using a translabial technique. Int Urogynecol J (2012) 0.84
Determination of fourteen non-steroidal anti-inflammatory drugs in animal serum and plasma by liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom (2006) 0.83
Hydrogen sulphide suppresses human atrial fibroblast proliferation and transformation to myofibroblasts. J Cell Mol Med (2013) 0.83
Arterial remodeling and atherosclerosis: miRNAs involvement. Vascul Pharmacol (2011) 0.83
Prognostic value of intraventricular bleeding in spontaneous intraparenchymal cerebral hemorrhage of small volume: a prospective cohort study. Neurosurgery (2012) 0.83
p300/cAMP-response-element-binding-protein ('CREB')-binding protein (CBP) modulates co-operation between myocyte enhancer factor 2A (MEF2A) and thyroid hormone receptor-retinoid X receptor. Biochem J (2003) 0.83